RIOK3_HUMAN - dbPTM
RIOK3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RIOK3_HUMAN
UniProt AC O14730
Protein Name Serine/threonine-protein kinase RIO3
Gene Name RIOK3
Organism Homo sapiens (Human).
Sequence Length 519
Subcellular Localization Cytoplasm .
Protein Description Involved in regulation of type I interferon (IFN)-dependent immune response which plays a critical role in the innate immune response against DNA and RNA viruses. May act as an adapter protein essential for the recruitment of TBK1 to IRF3. [PubMed: 24807708 Phosphorylates IFIH1 on 'Ser-828' interfering with IFIH1 filament assembly on long dsRNA and resulting in attenuated IFIH1-signaling]
Protein Sequence MDLVGVASPEPGTAAAWGPSKCPWAIPQNTISCSLADVMSEQLAKELQLEEEAAVFPEVAVAEGPFITGENIDTSSDLMLAQMLQMEYDREYDAQLRREEKKFNGDSKVSISFENYRKVHPYEDSDSSEDEVDWQDTRDDPYRPAKPVPTPKKGFIGKGKDITTKHDEVVCGRKNTARMENFAPEFQVGDGIGMDLKLSNHVFNALKQHAYSEERRSARLHEKKEHSTAEKAVDPKTRLLMYKMVNSGMLETITGCISTGKESVVFHAYGGSMEDEKEDSKVIPTECAIKVFKTTLNEFKNRDKYIKDDFRFKDRFSKLNPRKIIRMWAEKEMHNLARMQRAGIPCPTVVLLKKHILVMSFIGHDQVPAPKLKEVKLNSEEMKEAYYQTLHLMRQLYHECTLVHADLSEYNMLWHAGKVWLIDVSQSVEPTHPHGLEFLFRDCRNVSQFFQKGGVKEALSERELFNAVSGLNITADNEADFLAEIEALEKMNEDHVQKNGRKAASFLKDDGDPPLLYDE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8PhosphorylationMDLVGVASPEPGTAA
CCCCCCCCCCCCCCC
27.6523401153
13PhosphorylationVASPEPGTAAAWGPS
CCCCCCCCCCCCCCC
24.6822199227
20PhosphorylationTAAAWGPSKCPWAIP
CCCCCCCCCCCCCCC
42.8422199227
21UbiquitinationAAAWGPSKCPWAIPQ
CCCCCCCCCCCCCCC
47.66-
101UbiquitinationAQLRREEKKFNGDSK
HHHHHHHHHHCCCCC
58.89-
102UbiquitinationQLRREEKKFNGDSKV
HHHHHHHHHCCCCCE
47.55-
107PhosphorylationEKKFNGDSKVSISFE
HHHHCCCCCEEEEEE
36.0329759185
108UbiquitinationKKFNGDSKVSISFEN
HHHCCCCCEEEEEEC
44.7521890473
108 (in isoform 2)Ubiquitination-44.7521890473
108 (in isoform 1)Ubiquitination-44.7521890473
110PhosphorylationFNGDSKVSISFENYR
HCCCCCEEEEEECCE
19.0922210691
112PhosphorylationGDSKVSISFENYRKV
CCCCEEEEEECCEEE
20.9925159151
116PhosphorylationVSISFENYRKVHPYE
EEEEEECCEEECCCC
12.4725159151
122PhosphorylationNYRKVHPYEDSDSSE
CCEEECCCCCCCCCC
19.9323927012
125PhosphorylationKVHPYEDSDSSEDEV
EECCCCCCCCCCCCC
27.7023927012
127PhosphorylationHPYEDSDSSEDEVDW
CCCCCCCCCCCCCCC
39.3123927012
128PhosphorylationPYEDSDSSEDEVDWQ
CCCCCCCCCCCCCCC
54.8023927012
142PhosphorylationQDTRDDPYRPAKPVP
CCCCCCCCCCCCCCC
35.9028064214
146 (in isoform 1)Ubiquitination-49.5921890473
146 (in isoform 2)Ubiquitination-49.5921890473
146UbiquitinationDDPYRPAKPVPTPKK
CCCCCCCCCCCCCCC
49.5921906983
150PhosphorylationRPAKPVPTPKKGFIG
CCCCCCCCCCCCCCC
48.2330576142
152UbiquitinationAKPVPTPKKGFIGKG
CCCCCCCCCCCCCCC
68.92-
158UbiquitinationPKKGFIGKGKDITTK
CCCCCCCCCCCCCCC
58.95-
160UbiquitinationKGFIGKGKDITTKHD
CCCCCCCCCCCCCCC
49.82-
165UbiquitinationKGKDITTKHDEVVCG
CCCCCCCCCCEEECC
40.17-
197UbiquitinationDGIGMDLKLSNHVFN
CCCCCCHHHHHHHHH
45.68-
207 (in isoform 1)Ubiquitination-37.3121890473
207UbiquitinationNHVFNALKQHAYSEE
HHHHHHHHHHCCCHH
37.3121890473
207 (in isoform 2)Ubiquitination-37.3121890473
212PhosphorylationALKQHAYSEERRSAR
HHHHHCCCHHHHHHH
33.4928348404
217PhosphorylationAYSEERRSARLHEKK
CCCHHHHHHHHHHHH
24.7827282143
231UbiquitinationKEHSTAEKAVDPKTR
HCCCCHHHHCCHHHH
51.77-
236UbiquitinationAEKAVDPKTRLLMYK
HHHHCCHHHHHHHHH
41.64-
247PhosphorylationLMYKMVNSGMLETIT
HHHHHHHCCCHHHHH
17.7323532336
281UbiquitinationEDEKEDSKVIPTECA
CCCCCCCCCCCHHHH
57.41-
290 (in isoform 2)Ubiquitination-24.0821890473
290UbiquitinationIPTECAIKVFKTTLN
CCHHHHHHHHHHHHH
24.0821890473
290 (in isoform 1)Ubiquitination-24.0821890473
293UbiquitinationECAIKVFKTTLNEFK
HHHHHHHHHHHHHHH
43.52-
294PhosphorylationCAIKVFKTTLNEFKN
HHHHHHHHHHHHHHC
25.6730622161
295PhosphorylationAIKVFKTTLNEFKNR
HHHHHHHHHHHHHCC
28.3330622161
300 (in isoform 2)Ubiquitination-44.9121890473
300 (in isoform 1)Ubiquitination-44.9121890473
300UbiquitinationKTTLNEFKNRDKYIK
HHHHHHHHCCCCCCC
44.9121890473
304UbiquitinationNEFKNRDKYIKDDFR
HHHHCCCCCCCCCCC
45.71-
307UbiquitinationKNRDKYIKDDFRFKD
HCCCCCCCCCCCCHH
48.43-
318 (in isoform 2)Ubiquitination-49.9621890473
318 (in isoform 1)Ubiquitination-49.9621890473
318UbiquitinationRFKDRFSKLNPRKII
CCHHHHHHCCHHHHH
49.9621890473
348PhosphorylationRAGIPCPTVVLLKKH
HCCCCCCHHHHCCCC
29.9323403867
376UbiquitinationAPKLKEVKLNSEEMK
CCCCCEECCCHHHHH
42.94-
452 (in isoform 1)Ubiquitination-53.1021890473
452UbiquitinationNVSQFFQKGGVKEAL
CHHHHHHCCCHHHHH
53.1021890473
456 (in isoform 1)Ubiquitination-40.3121890473
456UbiquitinationFFQKGGVKEALSERE
HHHCCCHHHHHCHHH
40.3121890473
502UbiquitinationHVQKNGRKAASFLKD
HHHHHCHHHHHHHCC
50.10-
505PhosphorylationKNGRKAASFLKDDGD
HHCHHHHHHHCCCCC
35.6530576142
505 (in isoform 2)Ubiquitination-35.6521890473
508 (in isoform 1)Ubiquitination-52.3321890473
508UbiquitinationRKAASFLKDDGDPPL
HHHHHHHCCCCCCCC
52.332190698
517PhosphorylationDGDPPLLYDE-----
CCCCCCCCCC-----
26.2118083107

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseSMURF1Q9HCE7
PMID:20804422

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RIOK3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RIOK3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RUVB2_HUMANRUVBL2physical
17353931
SSRD_HUMANSSR4physical
17353931
FBRL_HUMANFBLphysical
17353931
PSB1_HUMANPSMB1physical
17353931
PRS6B_HUMANPSMC4physical
17353931
MAGA6_HUMANMAGEA6physical
17353931
SPT6H_HUMANSUPT6Hphysical
26496610
ZMAT3_HUMANZMAT3physical
26496610
OSBL5_HUMANOSBPL5physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RIOK3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-122; SER-127 ANDSER-128, AND MASS SPECTROMETRY.

TOP